{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23bv1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10066","date":"2023-08-15T14:23:57.253Z","role":"Publisher"},{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10066","date":"2023-06-28T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:3d05707a-ba95-41b6-ba8f-b470080cc5b4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:6fcdf1ef-603e-4745-93eb-9f79187ecb1e","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"ARMC9 antibody used to detect localization in ciliated hTERT-RPE1 cells. Localization was seen in the ciliary basal body and daughter centriole. There was also ARMC9 co-localization with Î³-tubulin in the basal body and daughter centriole.Expression was also noted to be upregulated in ciliated cells by quantitative PCR in human fibroblasts. This is consitent with previous works concluding that ciliary genes are upregulated during ciliogenesis and maintain upregulation in ciliated cells. (PMID: 18321927)\nPrevious studies have also identified ARMC9 as a cilium-associated protein (PMID: 22326026, PMID: 26585297)","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/28625504","type":"dc:BibliographicResource","dc:abstract":"Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterized by hypotonia, ataxia, abnormal eye movements, and variable cognitive impairment. It is defined by a distinctive brain malformation known as the \"molar tooth sign\" on axial MRI. Subsets of affected individuals have malformations such as coloboma, polydactyly, and encephalocele, as well as progressive retinal dystrophy, fibrocystic kidney disease, and liver fibrosis. More than 35 genes have been associated with JS, but in a subset of families the genetic cause remains unknown. All of the gene products localize in and around the primary cilium, making JS a canonical ciliopathy. Ciliopathies are unified by their overlapping clinical features and underlying mechanisms involving ciliary dysfunction. In this work, we identify biallelic rare, predicted-deleterious ARMC9 variants (stop-gain, missense, splice-site, and single-exon deletion) in 11 individuals with JS from 8 families, accounting for approximately 1% of the disorder. The associated phenotypes range from isolated neurological involvement to JS with retinal dystrophy, additional brain abnormalities (e.g., heterotopia, Dandy-Walker malformation), pituitary insufficiency, and/or synpolydactyly. We show that ARMC9 localizes to the basal body of the cilium and is upregulated during ciliogenesis. Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for ARMC9 as a ciliopathy-associated gene. Identifying ARMC9 mutations as a cause of JS takes us one step closer to a full genetic understanding of this important disorder and enables future functional work to define the central biological mechanisms underlying JS and other ciliopathies.","dc:creator":"Van De Weghe JC","dc:date":"2017","dc:title":"Mutations in ARMC9, which Encodes a Basal Body Protein, Cause Joubert Syndrome in Humans and Ciliopathy Phenotypes in Zebrafish."},"rdfs:label":"ARMC9 Localizes to the Basal Bodies of Primary Cilia"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"cggv:fbf82098-3bc2-4058-b4cc-dc2f58116a79","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:b1d0d662-d192-4e5e-80d9-526a8a74bd13","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"In situ hybridization of zebrafish armc9 revealed expression of armc9 in the brain, specifically in the cerebellum and periventricular regions, as well as in the retina","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504","rdfs:label":"zebrafish armc9 in situ hybridization"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:568a53ee-f285-4dbb-94d6-c85ce276d288","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"cggv:78511a4d-9be5-4aa6-8d66-56619fb0d65f","type":"FunctionalAlteration","dc:description":"All mutant cell lines had shortened cilia length compared to controls\n","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/32453716","type":"dc:BibliographicResource","dc:abstract":"Joubert syndrome (JBTS) is a recessive neurodevelopmental ciliopathy characterized by a pathognomonic hindbrain malformation. All known JBTS genes encode proteins involved in the structure or function of primary cilia, ubiquitous antenna-like organelles essential for cellular signal transduction. Here, we used the recently identified JBTS-associated protein armadillo repeat motif-containing 9 (ARMC9) in tandem-affinity purification and yeast 2-hybrid screens to identify a ciliary module whose dysfunction underlies JBTS. In addition to the known JBTS-associated proteins CEP104 and CSPP1, we identified coiled-coil domain containing 66 (CCDC66) and TOG array regulator of axonemal microtubules 1 (TOGARAM1) as ARMC9 interaction partners. We found that TOGARAM1 variants cause JBTS and disrupt TOGARAM1 interaction with ARMC9. Using a combination of protein interaction analyses, characterization of patient-derived fibroblasts, and analysis of CRISPR/Cas9-engineered zebrafish and hTERT-RPE1 cells, we demonstrated that dysfunction of ARMC9 or TOGARAM1 resulted in short cilia with decreased axonemal acetylation and polyglutamylation, but relatively intact transition zone function. Aberrant serum-induced ciliary resorption and cold-induced depolymerization in ARMC9 and TOGARAM1 patient cell lines suggest a role for this new JBTS-associated protein module in ciliary stability.","dc:creator":"Latour BL","dc:date":"2020","dc:title":"Dysfunction of the ciliary ARMC9/TOGARAM1 protein module causes Joubert syndrome."},"rdfs:label":"Altered cilia length"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:62ee8e10-b637-4413-bd81-17108c0ccda8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:d55dd5f3-8e22-4355-92c2-db4ef7d2584d","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"armc9 expressed in CNS regions (cerebellum, periventricular regions, and retina), body curvature corresponded with indels in the targeted exons. Gel electrophoresis showed armc9 indels in 11 fish, with all but one displaying body curvature. SEM identified reduction of cilia in brain ventricles in mutant fish. Retinal coloboma and shortened photoreceptors also exhibited in the fish with body curvature. These results support the function of armc9 in the functioning of cilia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504","rdfs:label":"Zebrafish armc9 Mutants Display Typical Ciliopathy Phenotype"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:11f60e83-578e-4f4e-a168-4786d6bef7af_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:11f60e83-578e-4f4e-a168-4786d6bef7af","type":"Proband","allele":{"id":"cggv:1236e78c-f65b-49f4-aae3-0f9f43018b99","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.601G>T (p.Glu201Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350948605"}},"detectionMethod":"parent-fetus trios WES\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001360","obo:HP_0010442","obo:HP_0000175","obo:HP_0034058","obo:HP_0002084"],"sex":"UnknownEthnicity","variant":{"id":"cggv:2bafd693-84ec-4e25-9962-4f079e5a93bc_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1236e78c-f65b-49f4-aae3-0f9f43018b99"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/30712878","type":"dc:BibliographicResource","dc:abstract":"Identification of chromosomal aneuploidies and copy number variants that are associated with fetal structural anomalies has substantial value. Although whole-exome sequencing (WES) has been applied to case series of a few selected prenatal cases, its value in routine clinical settings has not been prospectively assessed in a large unselected cohort of fetuses with structural anomalies. We therefore aimed to determine the incremental diagnostic yield (ie, the added value) of WES following uninformative results of standard investigations with karyotype testing and chromosomal microarray in an unselected cohort of sequential pregnancies showing fetal structural anomalies.","dc:creator":"Petrovski S","dc:date":"2019","dc:title":"Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study."}},"rdfs:label":"fetal 0108F"},{"id":"cggv:2bafd693-84ec-4e25-9962-4f079e5a93bc","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:2bafd693-84ec-4e25-9962-4f079e5a93bc_variant_evidence_item"}],"strengthScore":1.25,"dc:description":"Downgraded for homozygosity"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:23e5f064-8a91-4b77-8a0e-5f57a65bded8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:23e5f064-8a91-4b77-8a0e-5f57a65bded8","type":"Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":3,"allele":[{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1027C>T (p.Arg343Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2160165"}},{"id":"cggv:4fd24c60-e659-4380-9246-80b3cc88e3ce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1627-10A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2160427"}}],"detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0000508","obo:HP_0000486","obo:HP_0000639"],"sex":"Female","variant":[{"id":"cggv:0321d783-9dfe-46fb-a3e6-e7e91cd97d6d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/36580738","type":"dc:BibliographicResource","dc:abstract":"Joubert syndrome is a neurodevelopmental disorder with a distinctive hindbrain malformation called molar tooth sign, causing motor and cognitive impairments. More than 40 genes have been associated with Joubert syndrome. We aim to describe a group of Joubert syndrome patients clinically and genetically emphasizing organ involvement.","dc:creator":"Aksu Uzunhan T","dc:date":"2023","dc:title":"Clinical and genetic spectrum from a prototype of ciliopathy: Joubert syndrome."}},{"id":"cggv:7d380c57-3524-4894-81bc-717680dab3ff_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:4fd24c60-e659-4380-9246-80b3cc88e3ce"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/36580738"}],"rdfs:label":"Uzunhan Patient 3"},{"id":"cggv:0321d783-9dfe-46fb-a3e6-e7e91cd97d6d","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:0321d783-9dfe-46fb-a3e6-e7e91cd97d6d_variant_evidence_item"}],"strengthScore":0,"dc:description":"Recurrent variant"},{"id":"cggv:7d380c57-3524-4894-81bc-717680dab3ff","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:7d380c57-3524-4894-81bc-717680dab3ff_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:df3b4f2c-605a-4af3-a991-45c82b392926_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:df3b4f2c-605a-4af3-a991-45c82b392926","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":[{"id":"cggv:87972962-584e-4d8f-bbb4-6e6cb84160db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1474G>A (p.Gly492Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/427935"}},{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"entriculo- and cysto-peritoneal shunts, pituitary bright spot, superior and hemisphere cerebellar dysplasia, cervicomedulary heterotopia, Foramen magnum cephalcele, large posterior fossa with retro-cerebellar fluid, single L temporal Periventricular Nodular Heterotopia","phenotypes":["obo:HP_0002119","obo:HP_0007291","obo:HP_0000486","obo:HP_0001263","obo:HP_0002419","obo:HP_0001305","obo:HP_0007360","obo:HP_0002789","obo:HP_0000508","obo:HP_0007033","obo:HP_0001321","obo:HP_0001344","obo:HP_0002540"],"previousTesting":true,"previousTestingDescription":"MIPs targeted capture and array CGH for the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Male","variant":[{"id":"cggv:a0c139c1-cae1-4e7d-a8ac-17fa2582f501_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:87972962-584e-4d8f-bbb4-6e6cb84160db"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},{"id":"cggv:e10a95dc-c8b2-42fc-b231-dd9fd43f9281_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"}],"rdfs:label":"LR09-023"},{"id":"cggv:e10a95dc-c8b2-42fc-b231-dd9fd43f9281","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:e10a95dc-c8b2-42fc-b231-dd9fd43f9281_variant_evidence_item"}],"strengthScore":0,"dc:description":"Recurrent variant"},{"id":"cggv:a0c139c1-cae1-4e7d-a8ac-17fa2582f501","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:a0c139c1-cae1-4e7d-a8ac-17fa2582f501_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:1380b721-a1c9-4e87-9807-d8dae0615ed3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:1380b721-a1c9-4e87-9807-d8dae0615ed3","type":"Proband","ageType":"AgeAtReport","ageUnit":"WeeksGestation","ageValue":23,"allele":[{"id":"cggv:6c520fe2-d520-449a-9e46-cb37623cae47","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.485C>G (p.Ser162Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350947341"}},{"id":"cggv:881f7dd2-5d7a-479f-a149-b316de07e6f5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1878+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350963552"}}],"detectionMethod":"High throughput sequencing","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0007033","obo:HP_0001252","obo:HP_0000271","obo:HP_0100259","obo:HP_0001510","obo:HP_0002419","obo:HP_0001249"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"cggv:2071b31a-1521-4d22-b093-8e4fdff0dd2d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:881f7dd2-5d7a-479f-a149-b316de07e6f5"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/36584995","type":"dc:BibliographicResource","dc:abstract":"To explore the clinical characteristics and genetic basis of two Chinese pedigrees affected with Joubert syndrome.","dc:creator":"Zhao D","dc:date":"2023","dc:title":"[Clinical features and genetic analysis of two Chinese pedigrees affected with Joubert syndrome]."}},{"id":"cggv:8e756b1e-6837-41b1-b9e3-03b09378006b_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:6c520fe2-d520-449a-9e46-cb37623cae47"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/36584995"}],"rdfs:label":"Zhao pedigree 1 proband"},{"id":"cggv:8e756b1e-6837-41b1-b9e3-03b09378006b","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8e756b1e-6837-41b1-b9e3-03b09378006b_variant_evidence_item"}],"strengthScore":1.25,"dc:description":"Downgraded to account for the homozygosity in the Kar et al. and Becher et al. proband "},{"id":"cggv:2071b31a-1521-4d22-b093-8e4fdff0dd2d","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:2071b31a-1521-4d22-b093-8e4fdff0dd2d_variant_evidence_item"}],"strengthScore":0,"dc:description":"Recurrent variant"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:8d757981-f011-4333-a064-c7b127be222d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:8d757981-f011-4333-a064-c7b127be222d","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"cggv:d4babc41-6d3d-48e6-9878-6e5ba87f301e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.51+5G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA431718687"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"pituitary bright spot, superior cerebellar dysplasia, pituitary bright spot","phenotypes":["obo:HP_0001263","obo:HP_0002119","obo:HP_0007033","obo:HP_0000496","obo:HP_0000556","obo:HP_0002419","obo:HP_0000512"],"previousTesting":true,"previousTestingDescription":"MIPs and/or array CGH on the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Female","variant":{"id":"cggv:6b046945-8fbb-4cc0-a5b6-f7239b693485_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d4babc41-6d3d-48e6-9878-6e5ba87f301e"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},"rdfs:label":"UW348-3"},{"id":"cggv:6b046945-8fbb-4cc0-a5b6-f7239b693485","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:6b046945-8fbb-4cc0-a5b6-f7239b693485_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Should be downgraded for homozygosity at a total of 0.1 points. Due to limitations in the GCI, the score will be accounted for in the UW116-3 proband"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:9d436d76-d11f-4ba5-b7ab-4c923a152cfe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:9d436d76-d11f-4ba5-b7ab-4c923a152cfe","type":"Proband","allele":{"id":"cggv:52ba473a-3be9-4267-82c0-34d7f3b99828","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.879G>A (p.Thr293=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2160077"}},"detectionMethod":"Homozygosity mapping, using SNP array analysis ( Illumina Human-CytoSNO-12v2.1. DNA) on the entire family (including parents), and exome sequencing in all the siblings. All mutations were confirmed by Sanger sequencing in the proband, parents, siblings (affected and unaffected) and a control was used. WES identified mutations in the UGT1A7 gene (c.654A>C) within the shared chromosome 2 region, as well as ARMC( (c.879G>A). They also found mutations in the gene ZFPM1 (c.1331_1339delinsCCC), but this was not within any shared region of homozygosity between the siblings. Neither UGT1A7 or ZFPM1 is associated with a disease/ phenotype per OMIM.","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0007068","obo:HP_0002419","obo:HP_0000494","obo:HP_0006369","obo:HP_0000508","obo:HP_0000316","obo:HP_0001182","obo:HP_0000311","obo:HP_0000218","obo:HP_0002761","obo:HP_0030084","obo:HP_0010442","obo:HP_0001488","obo:HP_0006253","obo:HP_0004322","obo:HP_0001249","obo:HP_0005880"],"previousTestingDescription":"Authors stated that homozygosity mapping did not identify any significant CNVs. Loss of heterozygosity (greater than 1kb) were observed over all affected siblings in shromosome 2, 7, 10, and 14. The Chromosome 2q had a 11Mb region with 141 genes, of which none were associateed with ID, ptosis, and polydactyly together.","secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"cggv:a9390bf2-2cd3-451c-bec5-24c73edbb117_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:52ba473a-3be9-4267-82c0-34d7f3b99828"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29159890","type":"dc:BibliographicResource","dc:abstract":"Intellectual disability (ID) refers to deficits in mental abilities, social behavior, and motor skills to perform activities of daily living as compared to peers. Numerous genetic and environmental factors may be responsible for ID. We report on elucidation of molecular basis for syndromic ID associated with ptosis, polydactyly, and MRI features suggestive of Joubert syndrome using homozygosity mapping followed by exome sequencing. The analysis revealed a novel synonymous variation p.T293T (c.879G>A) which leads to a splicing defect in ARMC9 gene. The variant is present in conserved region of ARM domain of ARMC9 protein, which is predicted to form a platform for protein interaction. This domain is likely to be altered in patient due to splicing defect caused by this synonymous variation. Our report of variant in ARMC9 Leading to Joubert syndrome phenotype (JS30), elucidates the genetic heterogeneity of Joubert syndrome, and expands the gene list for ciliopathies.","dc:creator":"Kar A","dc:date":"2018","dc:title":"Whole exome sequencing reveals a mutation in ARMC9 as a cause of mental retardation, ptosis, and polydactyly."}},"rdfs:label":"Kar 2018 Family- II:1, male"},{"id":"cggv:a9390bf2-2cd3-451c-bec5-24c73edbb117","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:a9390bf2-2cd3-451c-bec5-24c73edbb117_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Should be downgraded for homozygosity at a total of 0.1 points. Due to limitations in the GCI, the score will be accounted for in the Zhao et al proband"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:44e51bf7-c01d-42a3-ae5f-37816b7e4221_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:44e51bf7-c01d-42a3-ae5f-37816b7e4221","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Transient neonatal apnea and tachypnea, superior cerebellar dysplasia, Foramen magnum cephalcele","phenotypes":["obo:HP_0000508","obo:HP_0002119","obo:HP_0001263","obo:HP_0007033","obo:HP_0000496","obo:HP_0002419"],"previousTesting":true,"previousTestingDescription":"MIPs and/or array CGH on the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Male","variant":{"id":"cggv:f138104b-bd7d-428a-bfe8-aef35f9a8ec4_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},"rdfs:label":"SA1-3"},{"id":"cggv:f138104b-bd7d-428a-bfe8-aef35f9a8ec4","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:f138104b-bd7d-428a-bfe8-aef35f9a8ec4_variant_evidence_item"}],"strengthScore":0,"dc:description":"Recurrent variant"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:2573889a-e213-4c01-9496-bfbb37f59d6e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2573889a-e213-4c01-9496-bfbb37f59d6e","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"cggv:34d9c428-0f7b-4d08-8075-7ce3d5017aae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1559C>T (p.Pro520Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/427936"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"absent posterior pituitary bright spot, superior and hemisphere cerebellar dysplasia","phenotypes":["obo:HP_0000508","obo:HP_0001263"],"previousTesting":true,"previousTestingDescription":"MIPs and/or array CGH on the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Female","variant":{"id":"cggv:26e928f3-ed6c-4843-b5b0-1063ac60e467_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:34d9c428-0f7b-4d08-8075-7ce3d5017aae"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},"rdfs:label":"SA2-3"},{"id":"cggv:26e928f3-ed6c-4843-b5b0-1063ac60e467","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:26e928f3-ed6c-4843-b5b0-1063ac60e467_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Should be downgraded for homozygosity at a total of 0.1 points. Due to limitations in the GCI, the score will be accounted for in the UW335-3 proband"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:2b2b6e51-e88d-4319-a7fe-cc2820be865a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2b2b6e51-e88d-4319-a7fe-cc2820be865a","type":"Proband","ageType":"AgeAtDeath","ageUnit":"WeeksGestation","ageValue":12,"allele":{"id":"cggv:53053e77-2289-4582-aeac-94083dc9375d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.443T>C (p.Phe148Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350947148"}},"detectionMethod":"Trio WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Brain malformations","phenotypes":"obo:HP_0002508","sex":"UnknownEthnicity","variant":{"id":"cggv:8720315d-fd6e-4369-a30d-9260ae558b2b_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:53053e77-2289-4582-aeac-94083dc9375d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/32304219","type":"dc:BibliographicResource","dc:abstract":"Applying whole-exome sequencing (WES) for the diagnosis of diseases in children has shown significant diagnostic strength compared with chromosomal microarray. WES may also have the potential of adding clinically relevant prenatal information in cases where a fetus is found to have structural anomalies. We present results from the first fetal exomes performed in a tertiary center in Denmark.","dc:creator":"Becher N","dc:date":"2020","dc:title":"Implementation of exome sequencing in fetal diagnostics-Data and experiences from a tertiary center in Denmark."}},"rdfs:label":"Case 14"},{"id":"cggv:8720315d-fd6e-4369-a30d-9260ae558b2b","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:8720315d-fd6e-4369-a30d-9260ae558b2b_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Should be downgraded for homozygosity at a total of 0.1 points. Due to limitations in the GCI, the score will be accounted for in the Zhao proband"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e482e3f3-51c9-4de1-9dcb-56f5ab77fdb5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e482e3f3-51c9-4de1-9dcb-56f5ab77fdb5","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":[{"id":"cggv:cfbc9127-a455-4c33-b896-8dfb319f339c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.259C>T (p.Arg87Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/427933"}},{"id":"cggv:675f42c5-498f-487e-b5d8-12708e90cc0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1027C>A (p.Arg343Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2160166"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"pituitary bright spot, single L occipital periventricular nodular heterotropia, superior and hemisphere cerebellar dysplasia","phenotypes":["obo:HP_0001263","obo:HP_0000496","obo:HP_0100543","obo:HP_0000486","obo:HP_0000657","obo:HP_0007033","obo:HP_0001290","obo:HP_0001251","obo:HP_0002419"],"previousTesting":true,"previousTestingDescription":"MIPs and/or array CGH on the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Female","variant":[{"id":"cggv:7852ba3b-a718-4c96-a45c-f6a5f178b8a5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:cfbc9127-a455-4c33-b896-8dfb319f339c"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},{"id":"cggv:7dd13df8-b9b1-40a2-beee-1985d05c8932_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:675f42c5-498f-487e-b5d8-12708e90cc0d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"}],"rdfs:label":"UW335-3"},{"id":"cggv:7852ba3b-a718-4c96-a45c-f6a5f178b8a5","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:7852ba3b-a718-4c96-a45c-f6a5f178b8a5_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:7dd13df8-b9b1-40a2-beee-1985d05c8932","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:7dd13df8-b9b1-40a2-beee-1985d05c8932_variant_evidence_item"}],"strengthScore":0,"dc:description":"0.1 points taken off to account for homozygosity in the SA2-3 proband"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:84c94b98-5d64-4dd4-bbe2-224d9640bd74_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:84c94b98-5d64-4dd4-bbe2-224d9640bd74","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":33,"allele":[{"id":"cggv:9ecf15d4-12ac-4c04-98a6-0d7fac062fbc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.205G>A (p.Gly69Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/427930"}},{"id":"cggv:a84177dc-ca67-4369-a3e0-0a0a91a694d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1336C>T (p.Arg446Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/427939"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"pituitary bright spot, superior cerebellar dysplasia, moderate size retrocerebellar fluid","phenotypes":["obo:HP_0007360","obo:HP_0007033","obo:HP_0001263","obo:HP_0001272","obo:HP_0002419","obo:HP_0000496"],"previousTesting":true,"previousTestingDescription":"MIPs and/or array CGH on the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Female","variant":[{"id":"cggv:54c84cf3-ba0c-4331-b2b7-9690dd8ae8cf_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a84177dc-ca67-4369-a3e0-0a0a91a694d6"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},{"id":"cggv:f6e6a556-8793-4ff6-9665-6f29159a7c2e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9ecf15d4-12ac-4c04-98a6-0d7fac062fbc"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"}],"rdfs:label":"UW132-3"},{"id":"cggv:f6e6a556-8793-4ff6-9665-6f29159a7c2e","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:f6e6a556-8793-4ff6-9665-6f29159a7c2e_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:54c84cf3-ba0c-4331-b2b7-9690dd8ae8cf","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:54c84cf3-ba0c-4331-b2b7-9690dd8ae8cf_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:8e697b27-5969-4f8a-b04d-7030cf666131_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:8e697b27-5969-4f8a-b04d-7030cf666131","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":[{"id":"cggv:e3fe0966-f212-4d54-bdb0-b48ddd7ab759","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1213_1334+2del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/427938"}},{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"}],"detectionMethod":"Performed array CGH targeting Joubert syndrome genes, or interested chromosomal regions and found a 2.5kB deletion encompassing exon 14 of ARMC9.","firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"Gastrostomy tube, pituitary bright spot, superior cerebellar dysplasia, single L occipital PVNH","phenotypes":["obo:HP_0002419","obo:HP_0001250","obo:HP_0002119","obo:HP_0002104","obo:HP_0001263","obo:HP_0002789","obo:HP_0000508","obo:HP_0007033","obo:HP_0000486","obo:HP_0007165","obo:HP_0000496"],"previousTesting":true,"previousTestingDescription":"MIPs and/or array CGH on the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Female","variant":[{"id":"cggv:c41aa1ff-e0c9-4511-bc19-d7536c380440_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e3fe0966-f212-4d54-bdb0-b48ddd7ab759"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},{"id":"cggv:1c524b57-f7f5-4016-9a25-e2ffa962f674_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"}],"rdfs:label":"UW116-3"},{"id":"cggv:1c524b57-f7f5-4016-9a25-e2ffa962f674","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:1c524b57-f7f5-4016-9a25-e2ffa962f674_variant_evidence_item"}],"strengthScore":0,"dc:description":"0.1 points taken off to account for homozygosity in the UW348-3 proband"},{"id":"cggv:c41aa1ff-e0c9-4511-bc19-d7536c380440","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:c41aa1ff-e0c9-4511-bc19-d7536c380440_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:bdbb9b6d-c201-4765-a43a-c0e90db5f6e3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:bdbb9b6d-c201-4765-a43a-c0e90db5f6e3","type":"Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":16,"allele":[{"id":"cggv:881f7dd2-5d7a-479f-a149-b316de07e6f5"},{"id":"cggv:223f3b01-a4f4-4bb0-b8e8-64edc603e052","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.895C>T (p.Arg299Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2160109"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002007","obo:HP_0001263","obo:HP_0000657","obo:HP_0002094","obo:HP_0000369","obo:HP_0000256","obo:HP_0001252","obo:HP_0007068","obo:HP_0000508","obo:HP_0005280","obo:HP_0002419"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"cggv:f70a2c3a-15da-4782-a466-770341f49ebf_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:881f7dd2-5d7a-479f-a149-b316de07e6f5"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/35186037","type":"dc:BibliographicResource","dc:creator":"Wang H","dc:date":"2022","dc:title":"Whole Exome Sequencing Identified Novel "}},{"id":"cggv:cceaa510-5477-4088-afeb-1d9939eaae8f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:223f3b01-a4f4-4bb0-b8e8-64edc603e052"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/35186037"}],"rdfs:label":"Family 1, Patient II-1"},{"id":"cggv:cceaa510-5477-4088-afeb-1d9939eaae8f","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:cceaa510-5477-4088-afeb-1d9939eaae8f_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:f70a2c3a-15da-4782-a466-770341f49ebf","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:f70a2c3a-15da-4782-a466-770341f49ebf_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:058e0e91-f149-4b62-ba6c-3e7324119e56_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:058e0e91-f149-4b62-ba6c-3e7324119e56","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":[{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"},{"id":"cggv:cf1f9a1d-0e1e-437c-80f3-2362472ee3b4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001352754.2(ARMC9):c.1474+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/427934"}}],"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"Eyelid Implants, possible hearing loss, borderline HSM, absent posterior pituitary bright spot, pituitary bright spot, superior cerebellar dysplasia, cervicomedulary heterotopia, Foramen magnum cephalcele","phenotypes":["obo:HP_0001263","obo:HP_0002282","obo:HP_0007033","obo:HP_0000496","obo:HP_0000508","obo:HP_0000824","obo:HP_0000218","obo:HP_0012793","obo:HP_0002104","obo:HP_0000054","obo:HP_0000193","obo:HP_0040075","obo:HP_0000347","obo:HP_0000609","obo:HP_0002419"],"previousTesting":true,"previousTestingDescription":"MIPs and/or array CGH on the following genes: AHI1, B9D1, B9D2, C2CD3, C5ORF42, CC2D2A, CEP290, CEP41, CSPP1, IFT172, INPP5E, KIF7, MKS1, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, and ZNF423.","sex":"Male","variant":[{"id":"cggv:1a0fe971-8d27-42a1-b862-b854f5ed4d05_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:57b8a465-9447-499e-9694-20b289d436bd"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"},{"id":"cggv:a971e14c-5fb6-49fe-a2d7-86cf87794920_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:cf1f9a1d-0e1e-437c-80f3-2362472ee3b4"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28625504"}],"rdfs:label":"UW349-3"},{"id":"cggv:1a0fe971-8d27-42a1-b862-b854f5ed4d05","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:1a0fe971-8d27-42a1-b862-b854f5ed4d05_variant_evidence_item"}],"strengthScore":0,"dc:description":"Recurrent variant"},{"id":"cggv:a971e14c-5fb6-49fe-a2d7-86cf87794920","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:a971e14c-5fb6-49fe-a2d7-86cf87794920_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":6715,"specifiedBy":"GeneValidityCriteria9","strengthScore":16,"subject":{"id":"cggv:bba8edca-ff42-4008-8eb1-f2f256ac8c2f","type":"GeneValidityProposition","disease":"obo:MONDO_0033308","gene":"hgnc:20730","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"*ARMC9* was first reported in relation to autosomal recessive Joubert Syndrome 30 in 2017 (PMID:28625504). Joubert syndrome is a rare genetic condition characterized by abnormal brain development that includes the absence or underdevelopment of the cerebellar vermis and a malformed brain stem. Seventeen variants (missense, nonsense, frameshift, splice site) reported in thirteen probands in seven publications (PMIDs: 28625504, 29159890, 35186037, 36584995, 36580738, 30712878, 32304219) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) was reached. This gene-disease association is also supported by a knockout zebrafish model, functional alteration data, and expression studies (PMIDs: 28625504, 32453716). In summary, *ARMC9* is âDefinitivelyâ associated with and defined as an autosomal recessive Ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy GCEP on the meeting date 6/28/2023 (SOP Version 9).","dc:isVersionOf":{"id":"cggv:77d8b454-195d-463c-b043-fc068392a23b"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}